Saturday 17 October 2026 Export OGN’s income statement to Excel — free account

Organon & Co.

OGN Healthcare Drug Manufacturers General

Organon & Co.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, down 2.92% from fiscal 2024. In the quarter to June 2026, revenue fell 2.26%, EPS fell 26.8%, free cash flow fell 83.0% and total debt fell 3.86%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

13.76 0.00 0.00%

Follow OGN

Alert me

Market cap: $3.6B
P/E: 17.4×
Fwd P/E: 5.2×
Dividend yield: 0.58%
F-score: 5/9
Altman Z: 1.09
Beneish M: −2.68
Dividend safety: 45/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	5.53	9.96	6.37	17.14
P/S ratio Full definition →		0.44	0.30	0.25	0.58
P/FCF ratio Full definition →		4.45	4.48	2.79	7.66
P/Operating CF Full definition →		10.52	13.20	6.93	33.23
P/B ratio Full definition →		3.06	2.47	1.73	3.53
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		1.74	1.60	1.46	1.79
EV/EBITDA Full definition →		7.07	6.92	6.33	7.78
EV/Operating CF Full definition →		11.52	14.19	10.60	14.89
EV/FCF Full definition →		17.52	23.93	16.09	23.66
Quick Ratio Full definition →		0.80	0.80	1.00	1.00
Current Ratio Full definition →		1.75	1.82	1.97	1.95
Net Debt/EBITDA Full definition →		19.51	30.45	23.59	18.06
Debt/Assets Full definition →		65.14%	67.18%	65.94%	64.90%
Debt/Equity Full definition →		9.74	11.49	9.49	8.50
Asset Turnover Full definition →		0.48	0.48	0.47	0.46
Operating CF/Net income Full definition →		1.65	(0.69)	1.54	0.99
Capex/Depreciation Full definition →		(1.92)	(0.13)	(0.46)	(0.85)
Interest Coverage Full definition →		2.80	(0.75)	2.12	2.98
Research and Development Expense of Revenue Full definition →		5.24%	6.04%	6.37%	5.78%
Selling, General and Administrative Expense of Revenue Full definition →		25.91%	28.73%	29.04%	27.86%
Intangible Assets out of Total Assets Full definition →		0.44	0.41	0.40	0.40
Share Based Compensation of Revenue Full definition →		1.50%	0.46%	1.30%	1.60%
Graham Net Nets Full definition →		(2.86)	(4.17)	(4.59)	(1.99)
Graham Number Full definition →		12.30	6.85	8.56	8.25
Earnings Yield Full definition →		18.07%	10.04%	15.69%	5.83%
Free Cash Flow Yield Full definition →		22.47%	22.30%	35.91%	13.05%
Revenue per Share Full definition →		6.16	5.81	5.61	5.93
Operating CF per Share Full definition →		1.02	0.54	0.86	0.41
Capex per Share Full definition →		(0.44)	(0.17)	(0.14)	(0.29)
Free Cash Flow per Share Full definition →		0.57	0.37	0.72	0.12
Cash per Share Full definition →		2.58	2.21	4.29	4.31
Shareholders Equity per Share Full definition →		3.49	2.90	3.47	3.83
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		3.49	2.90	3.47	3.83
Free Cash Flow Full definition →		149.00	96.00	188.00	31.00
Working Capital Full definition →		2,021.00	1,962.00	2,432.00	2,495.00
Capital Expenditures Full definition →		(115.00)	(45.00)	(37.00)	(76.00)
Net Current Asset Value Full definition →		(7,946.00)	(7,763.00)	(7,161.00)	(7,061.00)
EV/EBIT Full definition →		9.09	12.05	10.91	13.32
Capex to Sales Full definition →		0.07	0.03	0.03	0.05
Price to Operating Income Full definition →		2.31	2.26	1.89	4.32
Other line items
Average Receivables Full definition →		1,584.50	1,344.50	1,420.50	1,488.00
Average Payables Full definition →		1,083.00	1,052.50	994.50	1,059.00
Average Inventory Full definition →		1,435.50	1,363.50	1,367.50	1,402.50
Average Assets Full definition →		13,152.00	12,984.00	13,076.00	13,339.00
Average Common Equity Full definition →		699.50	612.00	722.50	869.50

Fold the line items

Columns are period end dates

Stockrow Weekly